Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) are Associated with the Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study
Under a Creative Commons license
open access
Abbreviations
ARDS
acute respiratory distress syndrome
CI
confidence interval
COVID-19
coronavirus disease 2019
CRP
C-reactive protein
ELISA
enzyme-linked immunosorbent assay
ICU
intensive care unit
LDH
lactate dehydrogenase
RT-PCR
reverse-transcriptase polymerase chain reaction
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
SD
standard deviation
suPAR
soluble urokinase Plasminogen Activator Receptor
UAE
United Arab Emirates
Keywords
COVID-19
Urokinase plasminogen activator
Acute respiratory distress syndrome
Intensive care admission
All-cause mortality
Cited by (0)
- 1
Joint first authors.
© 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.